Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Medondo Holding AG is a company dedicated to advancing digital solutions specifically for the healthcare industry. It primarily focuses on developing comprehensive software systems that improve the efficiency of medical practices and healthcare providers. Medondo provides a wide array of services including practice management software, which encompasses appointment scheduling, patient record management, and billing solutions, all tailored to streamline medical office operations. This integration is crucial for enhancing patient care, reducing administrative burdens, and ultimately optimizing workflow within healthcare facilities. By leveraging technology, Medondo Holding AG plays a significant role in transforming traditional healthcare practices into more adaptable and intelligent systems, ensuring seamless interaction between medical professionals and patients. As the healthcare sector continues to evolve with ongoing digital transformation, Medondo remains an impactful player, contributing to the modernization and technological advancement of this essential industry.
The business is unprofitable at the operating level (-209.31% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 16.7% YoY with margins expanding 95.7pp.
Negative free cash flow of -€2M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
€2M
▲ +16.7% YoY
Net Income (TTM)
-€4M
▲ +15.8% YoY
Op. Margin
-209.31%
▲ +95.7pp YoY
ROIC
-15.65%
▲ +2.4pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-€2M
▲ +21.5% YoY
Op. Cash Flow (TTM)
-€2M
▲ +21.4% YoY
Net Debt
€5M
Cash & Equiv.
€74K
3Y CAGR: -23.3%
Continue Research